
Candriam S.C.A. Raises Stake in Abbott Laboratories $ABT
Candriam S.C.A. grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 12.0% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 1,172,360 shares of the healthcare product maker’s stock after buying an additional 125,477 shares during the period. Abbott Laboratories accounts for approximately 0.8% of Candriam [...]








